# Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass

> **NCT02566733** · PHASE4 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 56 (actual)

## Conditions studied

- Anesthetics, Intravenous
- Pharmacology
- Anesthetics
- Cardiopulmonary Bypass

## Interventions

- **DRUG:** Remiva
- **DRUG:** Ultiva

## Key facts

- **NCT ID:** NCT02566733
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02566733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02566733, "Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02566733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*